Alvotech wins FDA for Humira biosimilar process (ALVO:NASDAQ)
· seekingalpha.com
Alvotech (ALVO) stock gains as the FDA OKs new manufacturing process for Simlandi, the company's Humira biosimilar marketed with Teva (TEVA). Read more here.
To ensure this doesn’t happen in the future, please enable Javascript and cookies in your browser.
If you have an ad-blocker enabled you may be blocked from ...